VMCS VisualMED Clinical Solutions Corporation (PK)

VisualMED Clinical Solutions Corp. (The "Company") (PINKSHEETS: VMCS) (FRANKFURT: VA6.F) announces today that it is expecting its revenues for the quarter ended June 30th, 2011 to rise to an amount between $890,000 and $965,000. This constitutes the most revenue in a single quarter in more than four years and represents a significant increase from the same quarter a year ago. These banner figures do allow the Company to provide further guidance regarding year end revenues for the entire exercise which is expected to reach as much as $1.2M to $1.3M.

Final year end results will be released during the last week of August. The Company is planning to hold a conference call immediately after filing 2011 year end results. This conference will be open to all investors and will address the 2011 financial results. Contact information will be provided on company website.

Company Chairman, Mr. Gerard Dab attributes the rising revenue trend to early adopters who desire to move forward ahead of the curve in seeking advanced medical informatics. The administration has been particularly proactive in pushing for better quality of healthcare delivery to patients in American healthcare facilities. For the first time general market conditions appear to favor the kind of advanced medical technology VisualMED offers.

ABOUT VISUALMED VisualMED markets smart Clinical Information Systems (CIS) with EHR and Computerized Physician Order Entry that are at the core of the new regulatory environment ushered in by the American Recovery and Reinvestment Act of 2009 and the Health Reform Act of 2010. We offer medical facilities and physicians a broad array of clinical applications with rich embedded clinical data, both scalable and interoperable, and whose high level of usability has been tested by over one thousand clinicians over many years in tertiary care and ambulatory environments. Our solutions help medical facilities increase provider efficiency, bring down operating costs, demonstrate meaningful use for ARRA grants and subsidies, and reduce mortality and morbidity. The Company's Suites of Medical Solutions operate on state of the art proprietary software platforms with advanced analytical capabilities provided by Visual Healthcare Corp. (NASDAQ OTC: VSHC).

Detailed information on our company and its products is available on our web site at www.visualmedsolutions.com

FORWARD-LOOKING STATEMENTS Except for historical information provided herein, this press release may contain information and statements of a forward-looking nature concerning the future performance of the Company. These statements are based on suppositions and uncertainties as well as on management's best possible evaluation of future events. Such factors may include, without excluding other considerations, fluctuations in quarterly results, evolution in customer demand for the Company's products and services, the impact of price pressures exerted by competitors, and general market trends or economic changes. As a result, readers are advised that actual results may differ from expected results.

For further information, please contact: FREDERICK BERLIN SALES MANAGER TEL: 514 836 1212 or 514 582 5220